Lexicon Pharmaceuticals, Inc.
LXRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12,769 | $3,252 | -$25,295 | -$33,766 |
| Dep. & Amort. | $151 | $176 | $176 | $125 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $3,195 | $3,043 | $1,537 |
| Change in WC | -$14,312 | $11,203 | -$19,237 | $11,768 |
| Other Non-Cash | $26,930 | -$833 | -$2,465 | -$1,155 |
| Operating Cash Flow | $0 | $16,993 | -$43,778 | -$21,491 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$474 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$26,725 | -$27,186 | -$66,297 | -$25,826 |
| Inv. Sales/Matur. | $78,850 | $41,455 | $105,553 | $80,000 |
| Other Inv. Act. | -$52,125 | $1,214 | $1,326 | $0 |
| Investing Cash Flow | $0 | $15,483 | $40,582 | $53,700 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$45,000 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | -$89 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$572 | -$15 |
| Financing Cash Flow | $0 | -$45,000 | -$572 | -$104 |
| Forex Effect | $28,292 | $0 | $0 | $0 |
| Net Chg. in Cash | $28,292 | -$12,524 | -$3,768 | $32,105 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21,364 | $62,888 | $66,656 | $34,551 |
| End Cash | $49,656 | $50,364 | $62,888 | $66,656 |
| Free Cash Flow | $0 | $16,993 | -$43,778 | -$21,965 |